Concepedia

J. Thomas Haskins

JT

Statistics

Publications

26

Citations

2.4K

H-Index

20

Active since

1978

Affiliations

Janssen (United States)(Current)

Janssen Scientific Affairs (United States)

University of Texas Health Science Center at Dallas

Johnson & Johnson (United States)

Experimental Pathology Laboratories

J. Thomas Haskins is an author at Janssen (United States) specializing in medicine, physiology, and neuroscience.

Top concepts

Publications per year

1978–2011

26

Publications

26

Antidepressant biochemical profile of the novel bicyclic compound Wy-45,030, an ethyl cyclohexanol derivative

Eric A. Muth, J. Thomas Haskins, John A. Moyer et al. · Biochemical Pharmacology · 1986 · 374 citations · Full text

, , +10

Efficacy, Safety, and Tolerability of Venlafaxine Extended Release and Buspirone in Outpatients With Generalized Anxiety Disorder

Jonathan R. T. Davidson, Robert L. DuPont, J. Thomas Haskins · The Journal of Clinical Psychiatry · 1999 · 303 citations

Efficacy of Venlafaxine Extended-Release Capsules in Nondepressed Outpatients With Generalized Anxiety Disorder

Alan J. Gelenberg, R. Bruce Lydiard, Richard L. Rudolph et al. · JAMA · 2000 · 293 citations

Efficacy of Extended-Release Venlafaxine in Nondepressed Outpatients With Generalized Anxiety Disorder

Karl Rickels, Mark H. Pollack, David V. Sheehan et al. · American Journal of Psychiatry · 2000 · 252 citations

WAY100135: a novel, selective antagonist at presynaptic and postsynaptic 5-HT1A receptors

Allan Fletcher, David J. Bill, Sarah J. Bill et al. · European Journal of Pharmacology · 1993 · 220 citations

, , +8

1–5 of 26